Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Canaccord G holds the target $55USD
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(17)
•••
Comment by sunshine7on Mar 28, 2016 8:42pm
120 Views
Post# 24706242

RE:Canaccord G holds the target $55USD

RE:Canaccord G holds the target $55USDAmazing how quickly positive news gets buried by garbage posts. Or is that the goal here?
sunshine7 wrote: He recognizes headwinds in US division resulting from supply issues and is impressed by AMCo division growth. Net analysis reduces 2016 EPS by 2 cents to $6.69 (in line with guidance) and maintains his $55USD target SP.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities